Immutep (IMMP) vs MIRA Pharmaceuticals (MIRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Immutep (IMMP) has outperformed MIRA Pharmaceuticals (MIRA) over the past year, gaining 78.8% versus a loss of 44.4%. MIRA Pharmaceuticals is the larger company by market cap ($31.3 million vs $26.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMMP | MIRA |
|---|---|---|
| Share price | $3.63 | $0.7455 |
| Market cap | $26.75M | $31.33M |
| 1-day change | -5.47% | +6.05% |
| YTD return | +26.92% | -50.63% |
| 1-year return | +78.82% | -44.37% |
| 5-year return | -8.10% | — |
| EPS (TTM) | $-7.30 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $70.60 | $2.45 |
| 52-week low | $3.55 | $0.60 |
| Distance from 52-week high | -94.86% | -69.57% |
| Analyst consensus | none | none |
| Avg. price target upside | +726.45% | +369.48% |
| Average volume | 14.85K | 585.75K |
| Shares outstanding | 7.37M | 42.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMP has outperformed MIRA by 123.2 percentage points over the past year.
About Immutep
IMMP stock →Immutep Limited, a clinical-stage biotechnology company, develops lymphocyte activation gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases in Australia. The company's lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on the LAG-3 immune control mechanism for the treatment of cancer.
Health Care · Biotechnology: Pharmaceutical Preparations
About MIRA Pharmaceuticals
MIRA stock →MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
Health Care · Biotechnology: Pharmaceutical Preparations
IMMP vs MIRA FAQ
Which is bigger, Immutep or MIRA Pharmaceuticals?
MIRA Pharmaceuticals (MIRA) is larger, with a market capitalization of $31.33M compared with $26.75M for Immutep (IMMP).
Which stock has performed better over the past year, IMMP or MIRA?
IMMP returned +78.82% over the past 12 months, compared with -44.37% for MIRA (price return, excluding dividends). Past performance does not predict future results.
Are Immutep and MIRA Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.